Viewpoint Molecular Targeting, Inc.
Pharmaceutical ManufacturingView the employees at
Viewpoint Molecular Targeting, Inc.-
Isabella Spoor University of Toronto
-
Montclair, New Jersey, United States
-
Rising Star
Joey Michael Radiation Safety Officer at Viewpoint Molecular Targeting-
North Liberty, Iowa, Amerika Serikat
-
Rising Star
Ephraim Obot, MS Director of Radiopharmaceutical Production at Viewpoint Molecular Targeting, Inc.-
Coralville, Iowa, United States
-
Rising Star
Edwin Sagastume Radioisotope Production Manager at Viewpoint Molecular Targeting, Inc.-
Iowa City, Iowa, United States
-
Rising Star
Overview
Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. The Company’s leading 𝛼-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary diagnostics that utilize the same targeting peptide which provide the opportunity to personalize treatment and optimize patient outcomes. This "theranostic” approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with many other types of cancer treatments. The Company’s melanoma (VMT01) and neuroendocrine tumor (VMT-𝛼-NET) programs are entering Phase 1 imaging studies, to be followed by Phase 1/2a therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at two leading academic institutions.
-